LITMIR.BIZ

Скачать книгу

across the road not far from the top of Mont Ventoux. He finally toppled over, then told a British team mechanic, “Get me up, get me up. I want to go on. I want to go straight. Get me up, get me straight.” Spectators helped him back onto his bike, but just one hundred meters later, he crumpled onto the road again, still gripping his handlebars as he went into a coma.

      Three hours later, he was dead. An autopsy report said he had died of heat prostration that led to a heart attack. But his jersey pockets told another story. In them were empty vials dusted with amphetamines.

      Don Catlin, the man who set up the United States’ first performance-enhancing drug testing laboratory, the UCLA Olympic Analytical Laboratory in Los Angeles, had been studying the drug erythropoietin, called EPO, from the start. It appeared on the market in the United States in 1989 as a drug used for kidney patients and AIDS-related anemia, but athletes long before that had learned of its magical powers. EPO is a powerful hormone that boosts endurance by increasing red blood cell production. More red blood cells mean more endurance. In the sport of road cycling, it turned out to be a miracle potion.

      The drug comes in a vial less than an inch and a half tall. But it is filled with several doses. No longer would endurance athletes have to undergo the dangerous and logistically difficult process of receiving blood transfusions to boost their red blood cell count. Now enhancing one’s endurance was as simple as pricking the skin with a needle. Athletes could receive what one unpublished Swedish study said was an average 8 percent boost in aerobic capacity. The study said the drug could cut 30 seconds from a 20-minute run. In cycling, using the drug could mean the difference between winning the Tour de France and not even qualifying for one’s Tour team.

      There was a frightening downside, though. EPO raised a rider’s hematocrit level—the proportion of red blood cells in the blood and a measure of blood’s thickness. A man’s hematocrit is usually between 42 and 48 percent of his whole blood.

      But with EPO, some cyclists were boosting their hematocrit into the 50s, or even higher. Bjarne Riis, the 1996 Tour champion, was even nicknamed “Mister 60 Percent” because EPO was rumored to have jacked up his hematocrit that high. The practice was inherently dangerous. If athletes overdosed on EPO, the drug would turn their blood to a viscous, sticky sludge that could cause a stroke or heart failure. Dehydration, which often occurs during long races, makes the blood even thicker. By the late 1980s, cyclists were buying the drug on the black market. Then they started dropping dead.

      In 1987, five Dutch riders died of heart problems. On August 17, 1988, Connie Meijer, a Dutch rider, passed out and died while competing in a criterium race. Diagnosis: heart attack. She was twenty-five. One day later, Bert Oosterbosch, another Dutch rider, died in his sleep, at thirty-two. Again, a heart attack.

      Doctors and blood specialists said EPO abuse might have played a role in the deaths of at least eighteen professional European cyclists in the years from 1988 to 1992. Ten deaths were attributed to heart problems. The cycling magazine VeloNews declared that “an atomic bomb” had gone off in the sport. News of the deaths was picked up by mainstream media outlets. The New York Times carried a headline: “Stamina-Building Drug Linked to Athletes’ Deaths.”

      Catlin sounded an alarm with the International Olympic Committee. As a member of the IOC’s medical commission, he pressed for an investigation. The athletes had taken a drug for which no test had yet been developed. Catlin believed the IOC should do something about it, and right away, because lives were at stake.

      He went with an IOC team to Europe on a fact-finding mission. He found no one who would talk about EPO. Family members refused to cooperate. Riders said they’d never heard of it. Basically, they told Catlin to go away. Again and again, he told them, Don’t be afraid to talk. We’re trying to save the lives of other cyclists. Please help us.

      In reply, he heard nothing. He believed that some people were protecting not only the memory of friends, family and teammates—they were also protecting the sport. Doping scandal followed doping scandal. Something had to be done.

      Catlin made his pitch in 1988. But the code of silence that had served cycling for so long could not be broken. Seven years later, Lance Armstrong used EPO for the first time.

      When Armstrong signed with the Motorola team in 1992, he had already fallen in with coaches of dubious repute. The first was Eddie Borysewicz.

      In 1985, Borysewicz was at the center of one of the biggest doping scandals in U.S. Olympic history. Borysewicz, a Pole, had honed his craft at sports academies in the Eastern bloc. While coach of the U.S. team at the 1984 Olympics, he was accused of pressuring riders to take transfusions of blood to get an increased supply of the oxygen-carrying red blood cells. If such transfusions were not done properly, or if the blood was not stored at the right temperature, blood doping could make a rider ill—or even kill him.

      The practice was not expressly prohibited by the International Olympic Committee, but its rules said athletes could not take any medication or undergo any procedures that would unfairly affect the competition. Whether forbidden or not, Borysewicz and other team officials watched seven members of the 1984 Olympic cycling team line up inside a room of the Ramada Inn in Los Angeles to wait their turn to lie on a bed and receive blood from a relative or someone else with the same blood type. Two riders became sick. Four went on to win medals, including a gold.

      Months later, the transfusions were made public, marring cycling’s image as well as Borysewicz’s reputation.

      “Eddie B. introduced hard-core doping to American cycling, and it’s never been the same,” says Andy Bohlmann, who from 1984 through 1990 was in charge of the antidoping program for the United States Cycling Federation, then the sport’s national governing body.

      In 1990, Chris Carmichael, a former rider on the 7-Eleven team, was appointed head coach of the national team, with dozens of cyclists under his command—including Armstrong and three other promising riders from the junior national team system. Those three were Greg Strock, Erich Kaiter and Gerrik Latta.

      Each of them would eventually claim that national team officials had doped them without their knowledge when they were teenagers. One pointed his finger at Carmichael. Those riders said they had received injections of substances that team officials claimed were merely vitamins or “extract of cortisone.” They said they were given unidentified pills embedded in candy bars to eat during races, and drank from water bottles spiked with banned performance enhancers.

      Years later, in medical school, Strock discovered that there is no such thing as “extract of cortisone.” He realized that his coaches had probably injected him with the real thing, which likely triggered the autoimmune disease that ended his cycling career in 1991. He thought back to the nationals in 1990, when, he claims, Carmichael had arrived with a briefcase full of drugs and syringes and allegedly injected Strock in the buttocks under the supervision of another coach, René Wenzel. Strock remembers seeing Carmichael at other races carrying that briefcase, looking like a pharmaceutical company representative heading to see his clients.

      Strock, Kaiter and Latta all sued USA Cycling, with Strock and Kaiter settling out of court. (The outcome of Latta’s case is unknown.) Carmichael allegedly paid Strock $20,000 to keep his name out of the lawsuit.

      And what did Lance Armstrong think of Carmichael? He told me they were like brothers. One of Carmichael’s future training videos would feature Armstrong’s photo on the box. Armstrong would write forewords for many of Carmichael’s books. All this work was done on the premise that Carmichael was the brains behind Lance Armstrong’s success. And you, too, could learn from the coach of the world’s greatest cyclists, especially if you attended one of Carmichael’s weeklong training camps. The cost: a cool $15,000.

      Throughout the 1990s, J.T. Neal acted as Armstrong’s main soigneur at some domestic races and at national team training camps. But in Europe and at the big races, the honor of rubbing down Armstrong went to a man named John Hendershot. Among soigneurs in the European peloton (another French word, one that refers to professional riders generally as well as the pack during a race), Hendershot was at once the cool kid and the calculating elder. Other soigneurs envied the money he made and

Скачать книгу